Table 2.
Renal expression of fibrosis pathway genes in transgenic B6-TGFβ and CBAxB6-TGFβ F1 mice at 14 days of age.
| Gene symbol | B6 (n=5) | CBAxB6 F1 (n=5) | B6-TGFβ (n=7) | CBAxB6-TGFβ F1 (n=7) | Kruskal-Wallis test |
|---|---|---|---|---|---|
| Tgfb1 | 1.00 ± 0.18 | 1.05 ± 0.12 | 0.80 ± 0.17 | 1.61 ± 0.42abc | p<0.0001 |
| Ctgf | 1.00 ± 0.19 | 0.69 ± 0.13 | 0.29 ± 0.06 | 1.88 ± 0.56abc | p<0.0001 |
| Bgn (biglycan) | 1.00 ± 0.39 | 0.37 ± 0.06 | 1.01 ± 0.23 | 1.78 ± 0.46abc | p<0.0001 |
| Dcn (decorin) | 1.00 ± 0.28 | 0.43 ± 0.13 | 1.09 ± 0.27c | 1.84 ± 0.43abc | p<0.0001 |
| Mmp2 | 1.00 ± 0.29 | 0.40 ± 0.21 | 0.97 ± 0.19 | 0.91 ± 0.38 | n.s. |
| Mmp9 | 1.00 ± 0.33 | 3.24 ± 0.57a | 0.88 ± 0.30c | 4.06 ± 1.04ab | p<0.0001 |
| Timp1 | 1.00 ± 0.53 | 0.52 ± 0.28 | 1.39 ± 0.45 | 108.48 ± 28.57abc | p<0.0001 |
| Timp2 | 1.00 ± 0.20 | 0.61 ± 0.08 | 0.98 ± 0.09 | 1.53± 0.11c | p<0.05 |
| Timp3 | 1.00 ± 0.21 | 1.31 ± 0.24 | 1.16 ± 0.07 | 1.35 ± 0.39 | n.s. |
| Tgbr2 | 1.00 ± 0.13 | 0.91 ± 0.15 | 1.03 ± 0.34 | 1.15 ± 0.16 | n.s. |
| Smad2 | 1.00 ± 0.34 | 0.72 ± 0.18 | 0.86 ± 0.14 | 0.95 ± 0.39 | n.s. |
| Smad3 | 1.00 ± 0.08 | 0.81 ± 0.19 | 0.89 ± 0.12 | 1.03 ± 0.23 | n.s. |
| Smad4 | 1.00 ± 0.28 | 0.85 ± 0.22 | 0.97 ± 0.12 | 0.91 ± 0.24 | n.s. |
| Smad6 | 1.00 ± 0.47 | 0.95 ± 0.39 | 1.12 ± 0.19 | 1.10 ± 0.60 | n.s. |
| Smad7 | 1.00 ± 0.10 | 0.70 ± 0.17 | 0.86 ± 0.11 | 1.07 ± 0.24 | n.s. |
Legend. Renal mRNA expression values of male TGF-β1 transgenic mice and male wild type controls at the age of 14 days. Expression of each gene was normalized to 18S rRNA (Rn18s) using the 2-ΔΔCt formula. Data are presented as fold expression to a pooled control sample (mean ± SD).
p<0.05 vs B6;
p<0.05 vs B6-TGFβ;
p<0.05 vs CBAxB6 F1.